• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

WHO: A(H7N9) candidate vaccine viruses, 13 Aug 2013

Biological

Closed. Please see Biological100
Summary of status of development and availability of avian influenza A(H7N9) candidate vaccine viruses
13 August 2013

Parent virus Candidate vaccine virus Type of virus or reassortant Developing institute Available from

A/Shanghai/2/2013
Synthetic HA&NA
IDCDC-RG32A* Reverse genetics CDC, USA CDC, USA
NIBRG-267** Reverse genetics NIBSC, UK NIBSC, UK
CBER-RG4A* Reverse genetics CBER, USA CBER, USA

A/Anhui/1/2013 Wild type virus WHO CCs
NIBRG-268* Reverse genetics NIBSC, UK NIBSC, UK
NIIDRG-10.1* Reverse genetics NIID, Japan NIID, Japan


* These viruses are candidate vaccine viruses which have passed relevant safety testing and two-way haemagglutination inhibition (HI) tests. They can be handled under BSL-2 enhanced containment1.
** These are potential candidate vaccine viruses which have passed relevant safety testing and can be handled under BSL-2 enhanced containment1. Full virus characterization is yet to be finished.

1 http://www.who.int/biologicals/areas/vaccines/influenza/biosafety_risk_assessment
Institutes contact details for candidate vaccine viruses orders/information:
CBER: Zhiping.Ye@fda.hhs.gov
CDC: rvd6@cdc.gov
NIBSC: standards@nibsc.org
NIID: nobusawa@nih.go.jp
WHO CCs: http://www.who.int/influenza/gisrs_laboratory/collaborating_centres/list/en/
For general enquiries, please contact gisrs-whohq@who.int
For other candidate vaccine viruses and potency testing reagents, please go to
http://www.who.int/influenza/vaccines/virus/candidates_rea

http://www.who.int/influenza/vaccines/virus/candidates_reagents/summary_a_h7n9_cvv_20130813.pdf

WHO | Candidate vaccine viruses for avian influenza A(H7N9)
http://www.who.int/influenza/vaccines/virus/candidates_reagents/a_h7n9/en/index.html
 
Back
Top Bottom